
President John Dramani Mahama is scheduled to commission new human DNA testing laboratories and a dedicated vaccine development facility at the Noguchi Memorial Institute for Medical Research (NMIMR) on Wednesday, November 18. The commissioning ceremony, which is set to take place at 2:00 p.m. in Accra, marks a significant expansion of the nation's premier biomedical research institution. These new installations are designed to provide the state with advanced tools for genetic analysis and pharmaceutical research, positioning Ghana at the forefront of medical innovation in the West African sub-region.
The Ministry of Health, which announced the upcoming launch, noted that the initiative is a response to the critical need for indigenous scientific infrastructure. By establishing these laboratories, the government aims to significantly reduce the current reliance on international facilities for complex medical and scientific investigations. Previously, many sensitive samples required transport to foreign laboratories for analysis, a process that often incurred high costs and delays in obtaining results. The new human DNA testing lab will streamline forensic and clinical investigations, while the vaccine development unit will focus on localizing the production and testing of essential immunisations.
This investment into the NMIMR highlights a strategic shift toward strengthening local public health systems and emergency preparedness. Officials emphasize that the ability to conduct high-level research within Ghana's borders is essential for managing future health crises more effectively. Following the official commissioning by President Mahama, the laboratories are expected to become operational immediately, providing services to both the medical community and state security agencies involved in forensic work. This development is seen as a major step toward achieving health sovereignty and enhancing the country's capacity for independent scientific breakthroughs.
Related topic
John Mahama: Latest News & Updates →